Analyze Diet
Arthritis and rheumatism2007; 56(7); 2335-2343; doi: 10.1002/art.22664

Hsp90 mediates insulin-like growth factor 1 and interleukin-1beta signaling in an age-dependent manner in equine articular chondrocytes.

Abstract: Many metabolic processes in chondrocytes thought to contribute to age-related changes in the extracellular matrix are influenced by known roles of Hsp90. Age-related decreases in the level of Hsp90 have been documented in numerous cell types and could contribute to cartilage degeneration. The aim of this study was to investigate the roles of age and Hsp90 in insulin-like growth factor 1 (IGF-1) and interleukin-1beta (IL-1beta) signaling in chondrocytes. Methods: Levels of Hsp90 messenger RNA (mRNA) and protein, with respect to age, were determined by quantitative real-time polymerase chain reaction (PCR) and Western blot analysis, respectively. The Hsp90 inhibitor geldanamycin (50 nM, 100 nM, or 500 nM) was used to assess age-related responses to Hsp90 with concurrent IGF-1 or IL-1beta stimulation of chondrocytes. Quantitative real-time PCR was used to measure COL2A1 and matrix metalloproteinase 13 (MMP13) gene expression; Western blot analysis was performed to determine the phosphorylation status of p42/44 and Akt/protein kinase B. Results: The effects of Hsp90 inhibition with geldanamycin were concentration dependent. Inhibition of Hsp90 with 100 nM or 500 nM geldanamycin blocked IGF-1-induced cell proliferation, Akt and p42/44 activation, and COL2A1 expression. Basal and IL-1beta-induced up-regulation of MMP13 mRNA was blocked by all concentrations of geldanamycin tested. Gain-of-function assays with Hsp90 resulted in increased expression of MMP13 mRNA. Conclusions: These results suggest that Hsp90 is involved in opposing signaling pathways of cartilage homeostasis, and that catabolic responses are more sensitive to Hsp90 inhibition than are anabolic responses. Further studies are needed to determine the role of Hsp90 inhibition in osteoarthritis in order to assess its potential as a therapeutic target.
Publication Date: 2007-06-30 PubMed ID: 17599753DOI: 10.1002/art.22664Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • N.I.H.
  • Extramural

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research primarily focuses on how the protein Hsp90 affects aging-related changes in cartilage cells or chondrocytes, with special focus on how these interactions influence the signaling of insulin-like growth factor 1 and interleukin-1beta, factors linked to cellular growth and inflammation respectively.

Objective and Methodology

  • The primary objective was to investigate the impact of age and the protein Hsp90 on signaling pathways of insulin-like growth factor 1 (IGF-1) and interleukin-1beta (IL-1beta) in chondrocytes, cells that are critical in cartilage health and maintenance.
  • To complete this study, the researchers measured levels of Hsp90 mRNA and protein by conducting quantitative real-time polymerase chain reaction (PCR) and Western blot analysis respectively.
  • Hsp90 inhibitor geldanamycin was used on the chondrocytes to assess how inhibition of Hsp90 affects the responses to IGF-1 or IL-1beta stimulation, studying concentrations of 50 nM, 100 nM, or 500 nM.
  • Tests conducted also included measuring levels of COL2A1 and matrix metalloproteinase 13 (MMP13) gene expression using quantitative real-time PCR, with the protein expression measured using Western blot analysis.

Results and Conclusion

  • The outcomes displayed that effects of Hsp90 inhibition through geldanamycin were concentration dependent.
  • Specially, with 100 nM or 500 nM geldanamycin, IGF-1 induced cell growth, activation of Akt and p42/44, and COL2A1 expression were blocked.
  • Baseline and IL-1beta-induced upregulation of MMP13 mRNA was obstructed by all concentrations of geldanamycin used in the study.
  • The overexpression of Hsp90 resulted in an increase in MMP13 mRNA expression.
  • The concluding message from the research was that Hsp90 is involved in both the growth and breakdown signaling pathways of cartilage homeostasis. Intriguingly, the breakdown pathways appeared more sensitive to Hsp90 inhibition than the growth pathways.
  • This recognises the potential of further exploration into the role of Hsp90 inhibition in osteoarthritis, to evaluate it as a possible therapeutic target.

Cite This Article

APA
Boehm AK, Seth M, Mayr KG, Fortier LA. (2007). Hsp90 mediates insulin-like growth factor 1 and interleukin-1beta signaling in an age-dependent manner in equine articular chondrocytes. Arthritis Rheum, 56(7), 2335-2343. https://doi.org/10.1002/art.22664

Publication

ISSN: 0004-3591
NlmUniqueID: 0370605
Country: United States
Language: English
Volume: 56
Issue: 7
Pages: 2335-2343

Researcher Affiliations

Boehm, Amber K
  • Cornell University, Veterinary Medical Center, Ithaca, New York 14853, USA.
Seth, Mayank
    Mayr, Karen G
      Fortier, Lisa A

        MeSH Terms

        • Aging
        • Animals
        • Benzoquinones / pharmacology
        • Cartilage, Articular / growth & development
        • Cartilage, Articular / physiology
        • Chondrocytes / physiology
        • Collagen Type II
        • Gene Expression Regulation, Developmental
        • HSP90 Heat-Shock Proteins / genetics
        • Horses
        • Insulin-Like Growth Factor I / physiology
        • Interleukin-1beta / physiology
        • Lactams, Macrocyclic / pharmacology
        • Matrix Metalloproteinases / genetics
        • Polymerase Chain Reaction
        • RNA, Messenger / genetics
        • Signal Transduction

        Grant Funding

        • AG-00905 / NIA NIH HHS

        Citations

        This article has been cited 20 times.
        1. Cook J, Greene ES, Ramser A, Mullenix G, Dridi JS, Liyanage R, Wideman R, Dridi S. Comparative- and network-based proteomic analysis of bacterial chondronecrosis with osteomyelitis lesions in broiler's proximal tibiae identifies new molecular signatures of lameness. Sci Rep 2023 Apr 12;13(1):5947.
          doi: 10.1038/s41598-023-33060-ypubmed: 37045932google scholar: lookup
        2. Takeuchi Y, Tatsuta S, Kito A, Fujikawa J, Itoh S, Itoh Y, Akiyama S, Yamashiro T, Wakisaka S, Abe M. Kruppel-like factor 4 upregulates matrix metalloproteinase 13 expression in chondrocytes via mRNA stabilization. Cell Tissue Res 2020 Nov;382(2):307-319.
          doi: 10.1007/s00441-020-03228-3pubmed: 32556726google scholar: lookup
        3. Barbon S, Stocco E, Macchi V, Contran M, Grandi F, Borean A, Parnigotto PP, Porzionato A, De Caro R. Platelet-Rich Fibrin Scaffolds for Cartilage and Tendon Regenerative Medicine: From Bench to Bedside. Int J Mol Sci 2019 Apr 5;20(7).
          doi: 10.3390/ijms20071701pubmed: 30959772google scholar: lookup
        4. Grilz-Seger G, Druml T, Neuditschko M, Dobretsberger M, Horna M, Brem G. High-resolution population structure and runs of homozygosity reveal the genetic architecture of complex traits in the Lipizzan horse. BMC Genomics 2019 Mar 5;20(1):174.
          doi: 10.1186/s12864-019-5564-xpubmed: 30836959google scholar: lookup
        5. Erekat N, Al-Jarrah MD. Interleukin-1 Beta and Tumor Necrosis Factor Alpha Upregulation and Nuclear Factor Kappa B Activation in Skeletal Muscle from a Mouse Model of Chronic/Progressive Parkinson Disease. Med Sci Monit 2018 Oct 22;24:7524-7531.
          doi: 10.12659/MSM.909032pubmed: 30344306google scholar: lookup
        6. Gugjoo MB, Sharma GT, Aithal HP, Kinjavdekar P. Cartilage tissue engineering: Role of mesenchymal stem cells along with growth factors & scaffolds. Indian J Med Res 2016 Sep;144(3):339-347.
          doi: 10.4103/0971-5916.198724pubmed: 28139532google scholar: lookup
        7. Shi L, Banerjee D, Dobierzewska A, Sathishkumar S, Karakashian AA, Giltiay NV, Nikolova-Karakashian MN. Direct regulation of IGF-binding protein 1 promoter by interleukin-1β via an insulin- and FoxO-1-independent mechanism. Am J Physiol Endocrinol Metab 2016 Apr 15;310(8):E612-E623.
          doi: 10.1152/ajpendo.00289.2015pubmed: 26884383google scholar: lookup
        8. Calamia V, Mateos J, Fernández-Puente P, Lourido L, Rocha B, Fernández-Costa C, Montell E, Vergés J, Ruiz-Romero C, Blanco FJ. A pharmacoproteomic study confirms the synergistic effect of chondroitin sulfate and glucosamine. Sci Rep 2014 Jun 10;4:5069.
          doi: 10.1038/srep05069pubmed: 24912619google scholar: lookup
        9. Wann AK, Chapple JP, Knight MM. The primary cilium influences interleukin-1β-induced NFκB signalling by regulating IKK activity. Cell Signal 2014 Aug;26(8):1735-42.
          doi: 10.1016/j.cellsig.2014.04.004pubmed: 24726893google scholar: lookup
        10. Krüger JP, Freymannx U, Vetterlein S, Neumann K, Endres M, Kaps C. Bioactive factors in platelet-rich plasma obtained by apheresis. Transfus Med Hemother 2013 Dec;40(6):432-40.
          doi: 10.1159/000356329pubmed: 24474894google scholar: lookup
        11. Lotz M, Loeser RF. Effects of aging on articular cartilage homeostasis. Bone 2012 Aug;51(2):241-8.
          doi: 10.1016/j.bone.2012.03.023pubmed: 22487298google scholar: lookup
        12. Calamia V, de Andrés MC, Oreiro N, Ruiz-Romero C, Blanco FJ. Hsp90β inhibition modulates nitric oxide production and nitric oxide-induced apoptosis in human chondrocytes. BMC Musculoskelet Disord 2011 Oct 17;12:237.
          doi: 10.1186/1471-2474-12-237pubmed: 22004293google scholar: lookup
        13. Fortier LA, Barker JU, Strauss EJ, McCarrel TM, Cole BJ. The role of growth factors in cartilage repair. Clin Orthop Relat Res 2011 Oct;469(10):2706-15.
          doi: 10.1007/s11999-011-1857-3pubmed: 21403984google scholar: lookup
        14. Loeser RF. Age-related changes in the musculoskeletal system and the development of osteoarthritis. Clin Geriatr Med 2010 Aug;26(3):371-86.
          doi: 10.1016/j.cger.2010.03.002pubmed: 20699160google scholar: lookup
        15. Beier F, Loeser RF. Biology and pathology of Rho GTPase, PI-3 kinase-Akt, and MAP kinase signaling pathways in chondrocytes. J Cell Biochem 2010 Jun 1;110(3):573-80.
          doi: 10.1002/jcb.22604pubmed: 20512918google scholar: lookup
        16. Swindell WR. Heat shock proteins in long-lived worms and mice with insulin/insulin-like signaling mutations. Aging (Albany NY) 2009 Jun 15;1(6):573-7.
          doi: 10.18632/aging.100058pubmed: 20157538google scholar: lookup
        17. Li R, Pourpak A, Morris SW. Inhibition of the insulin-like growth factor-1 receptor (IGF1R) tyrosine kinase as a novel cancer therapy approach. J Med Chem 2009 Aug 27;52(16):4981-5004.
          doi: 10.1021/jm9002395pubmed: 19610618google scholar: lookup
        18. Zhao B, Deng Z, Yang Z, Yang F, Yang W. Heat shock proteins in osteoarthritis: molecular mechanisms, pathogenic roles, and therapeutic opportunities. Front Immunol 2025;16:1688250.
          doi: 10.3389/fimmu.2025.1688250pubmed: 41472751google scholar: lookup
        19. Ro DH, Cho GH, Kim JY, Min SK, Yang HR, Park HJ, Wang SY, Kim YJ, Lee MC, Bae HC, Han HS. Selective targeting of dipeptidyl-peptidase 4 (DPP-4) positive senescent chondrocyte ameliorates osteoarthritis progression. Aging Cell 2024 Jul;23(7):e14161.
          doi: 10.1111/acel.14161pubmed: 38556837google scholar: lookup
        20. Yang X, Han L, Ye Q, Wang H, Zhang J, Wang W, Xiao H, Wang Y, Wang L, Ding J. MethylRAD Sequencing Technology Reveals DNA Methylation Characteristics of Apostichopus japonicus of Different Ages. Animals (Basel) 2023 Nov 15;13(22).
          doi: 10.3390/ani13223530pubmed: 38003147google scholar: lookup